Welcome to our dedicated page for Encompass Health news (Ticker: EHC), a resource for investors and traders seeking the latest updates and insights on Encompass Health stock.
Encompass Health Corporation reports developments tied to its role as an operator of inpatient rehabilitation hospitals in the United States. Company news commonly covers hospital openings and capacity additions, rehabilitative care for patients recovering from strokes, neurological disorders, brain and spinal cord injuries, amputations and complex orthopedic conditions, and updates from its national hospital network.
Recurring announcements also include quarterly operating results, same-store discharge trends, net patient revenue per discharge, cash dividends on common stock, investor conference participation and annual stockholder meeting matters. These updates connect Encompass Health's post-acute care model with its hospital expansion activity, patient-volume measures, reimbursement-sensitive revenue trends and public-company governance calendar.
Encompass Health (NYSE:EHC) priced a private offering of an additional $100 million aggregate principal amount of its 5.875% senior notes due 2034 at 98.75% of principal. The Additional Notes reopen the 2034 series issued in May 2026, share the same terms, and pay interest semiannually on June 1 and Dec. 1, starting Dec. 1, 2026.
The notes will be senior unsecured obligations, jointly and severally guaranteed by existing and future subsidiary guarantors under the company's credit agreement and other capital markets debt. Encompass Health expects to close the offering on August 13, 2026 and intends to use net proceeds, along with cash on hand, to repay outstanding amounts under its senior secured revolving credit facility. The offering is limited to qualified institutional buyers under Rule 144A and certain non-U.S. investors under Regulation S and will not be registered under the Securities Act.
Encompass Health (NYSE: EHC) has launched a private offering of an additional $100 million aggregate principal amount of 5.875% senior notes due 2034. These Additional Notes reopen the 5.875% notes first issued in May 2026 and will form the same class, with identical terms except for issuance date and offering price.
The notes will be senior unsecured and jointly and severally guaranteed by subsidiaries that guarantee borrowings under the company’s credit agreement and other capital markets debt. Encompass Health plans to use net proceeds, together with cash on hand, to repay outstanding amounts under its senior secured revolving credit facility. The offering is a private placement under Rule 144A and Regulation S and is not registered under the Securities Act.
Encompass Health (NYSE:EHC) reported Q2 2026 net operating revenue of $1.60 billion, up 9.6% year over year, with Adjusted EBITDA of $348.0 million (+9.2%). Diluted income from continuing operations per share and adjusted EPS were both $1.55, up 10.7%.
Discharges rose 5.6% to 68,895 and net patient revenue per discharge increased 3.9%. Operating cash flow was $282.6 million (+4.6%), while adjusted free cash flow declined 4.8% to $177.0 million.
The company raised full‑year 2026 guidance to net operating revenue of $6.41–$6.49 billion, Adjusted EBITDA of $1.365–$1.395 billion, and adjusted EPS of $6.02–$6.25. The board also increased aggregate common stock repurchase authorization to $1 billion; $145.8 million was repurchased year to date.
Encompass Health (NYSE:EHC) announced that its board of directors approved a $0.02 increase in the quarterly dividend on its common stock, bringing it to $0.21 per share. The cash dividend is payable on October 15, 2026, to shareholders of record on October 1, 2026.
Encompass Health (NYSE:EHC) will report 2026 second quarter results after market close on Wednesday, Aug. 5, 2026. The company will host an investor conference call at 10 a.m. ET on Thursday, Aug. 6, 2026 to discuss its results.
Investors can access the call by phone using conference ID EHCQ226 or via live webcast and replay on the Encompass Health investor relations website.
Encompass Health (NYSE:EHC) and Piedmont have opened Eastside Rehabilitation Hospital, a 40-bed inpatient rehabilitation facility in Loganville, Georgia, now accepting patients.
The more than 52,000-square-foot, state-of-the-art hospital offers intensive therapy, 24-hour nursing, advanced rehab technologies and expands Encompass Health’s presence to nine hospitals in Georgia and eight joint ventures with Piedmont.
Big Brothers Big Sisters of America elected veteran healthcare and financial services executive Cain A. Hayes to its National Board of Directors. Hayes brings 35+ years of leadership in strategic growth, health equity and governance, and currently serves on the boards of DocuSign (NASDAQ:DOCU) and Encompass Health (NYSE:EHC).
His appointment supports BBBSA’s goal to expand proven mentoring models and reach more than 10 million young people nationwide.
Encompass Health (NYSE:EHC) plans to build a new freestanding, 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, replacing its former 19-bed unit at WVU Medicine United Hospital Center.
The facility will offer private rooms, advanced therapy technologies, an in-house dialysis suite and comprehensive rehabilitation services.
Encompass Health (NYSE:EHC) has issued a notice to redeem $400 million of its 4.500% senior notes due 2028. The notes will be redeemed at 100% of par plus accrued interest, with payment expected on June 15, 2026.
The company expects to record an approximate $3.2 million loss on early extinguishment of debt in Q2 2026, leaving $400 million of these notes outstanding after redemption.
Encompass Health (NYSE:EHC) priced a private offering of $500 million in 5.875% senior notes due 2034 at 100% of principal. Interest is payable semiannually starting Dec. 1, 2026. Closing is expected May 29, 2026, with proceeds earmarked to refinance existing debt and pay related fees.